Iovance Biotherapeutics Appoints Noah Berkowitz as Chief Medical Officer

Iovance Biotherapeutics, Inc. has appointed Noah Berkowitz, M.D., Ph.D., as its Chief Medical Officer. Dr. Berkowitz is a leader in the global drug development of T cell therapies.